EAM
Exane Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,000
| Closed | -$969K | – | 30 |
|
|
2024
Q3 | $969K | Buy |
+5,000
| New | +$969K | 0.78% | 15 |
|
|
2018
Q3 | – | Sell |
-40,708
| Closed | -$11.8M | – | 131 |
|
|
2018
Q2 | $11.8M | Buy |
40,708
+2,363
| +6% | +$686K | 5.11% | 5 |
|
|
2018
Q1 | $10.5M | Sell |
38,345
-38,051
| -50% | -$10.4M | 3.15% | 12 |
|
|
2017
Q4 | $24.3M | Buy |
76,396
+1,448
| +2% | +$461K | 7.56% | 3 |
|
|
2017
Q3 | $23.5M | Buy |
74,948
+8,826
| +13% | +$2.76M | 4.59% | 10 |
|
|
2017
Q2 | $17.9M | Buy |
+66,122
| New | +$17.9M | 5.6% | 9 |
|
|
2016
Q4 | – | Sell |
-8,500
| Closed | -$2.66M | – | 37 |
|
|
2016
Q3 | $2.66M | Buy |
+8,500
| New | +$2.66M | 0.83% | 28 |
|
|
2016
Q2 | – | Sell |
-73
| Closed | -$19K | – | 33 |
|
|
2016
Q1 | $19K | Buy |
+73
| New | +$19K | 0.01% | 23 |
|